SR, G., SA, S., MW, B., M, S., S, V., JM, E., . . . MM, H. (2025). Polypharmacy and pharmacogenomics in high-acuity behavioral health care for autism spectrum disorder: A retrospective study. Child and adolescent psychiatry and mental health, 19(1), 60. https://doi.org/10.1186/s13034-025-00915-3
Chicago Style (17th ed.) CitationSR, Garrison, Schweinert SA, Boyer MW, Singh M, Vadapalli S, Engelmann JM, Schwartz RA, and Hartig MM. "Polypharmacy and Pharmacogenomics in High-acuity Behavioral Health Care for Autism Spectrum Disorder: A Retrospective Study." Child and Adolescent Psychiatry and Mental Health 19, no. 1 (2025): 60. https://doi.org/10.1186/s13034-025-00915-3.
MLA (9th ed.) CitationSR, Garrison, et al. "Polypharmacy and Pharmacogenomics in High-acuity Behavioral Health Care for Autism Spectrum Disorder: A Retrospective Study." Child and Adolescent Psychiatry and Mental Health, vol. 19, no. 1, 2025, p. 60, https://doi.org/10.1186/s13034-025-00915-3.